Figure 1. MiR-487a-3p is significantly up-regulated in tumor tissue of rectal cancer patients with poor response to neoadjuvant chemoradiotherapy (A) and based on the ROC analysis miR-487a-3p can distinguish responders (TRG 1,2) and non-responders (TRG 4,5) to this therapy (B). ***pvalue<0.001; AUC, Area under curve.
